Chronic pain, affecting over 1.5 billion people worldwide, is a leading cause of disability, reducing quality of life and productivity. Traditional pain management relies on opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and physical therapy, but these approaches often carry risks of addiction, gastrointestinal damage, or limited efficacy. Cannabidiol (CBD), a non-psychoactive compound from Cannabis sativa, has…
Cannabidiol (CBD), a non-psychoactive compound derived from Cannabis sativa, has surged in popularity over the past decade, transforming from a niche herbal remedy to a mainstream wellness product. Found in oils, gummies, creams, and even pet products, CBD is marketed for its potential to alleviate conditions like anxiety, chronic pain, insomnia, and epilepsy. Its appeal…
Cannabidiol (CBD), a non-psychoactive compound derived from Cannabis sativa, has surged in popularity over the past decade, transforming from a niche herbal remedy to a mainstream wellness product. Found in oils, gummies, creams, and even pet products, CBD is marketed for its potential to alleviate conditions like anxiety, chronic pain, insomnia, and epilepsy. Its appeal…